Amazon Pharmacy's low-priced Wegovy rollout raises fresh concerns about pricing power and market share for telehealth players ...

Hims & Hers Health, Inc. (HIMS) closed at $28.89 in the latest trading session, marking a -5.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 1.16% for the ...

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on January 8, 2026, ...

Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right ...

Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Learn more about HIMS stock here.

Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health (NYSE:HIMS) revealed 13 unusual trades. Delving into the details, we ...

Hims & Hers (NYSE: HIMS) is adding another specialty in an effort to build out its healthcare platform. The company has brought testosterone to the market, the first big addition since weight loss in ...

Detailed price information for American Well Corp Cl A (AMWL-N) from The Globe and Mail including charting and trades.

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and GoodRx Holdings, Inc. GDRX among the leaders in this digital shift. HIMS is a consumer-first, ...

Here's a look at the top 10 most heavily shorted stocks, including Lucid, MARA, Avis, Kohl's and Hims & Hers Health.